OPK
Income statement / Annual
Last year (2023), OPKO Health, Inc.'s total revenue was $863.50 M,
a decrease of 14.01% from the previous year.
In 2023, OPKO Health, Inc.'s net income was -$188.86 M.
See OPKO Health, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$863.50 M
|
$1.00 B
|
$1.77 B
|
$1.44 B
|
$901.90 M
|
$990.30 M
|
$966.01 M
|
$1.22 B
|
$491.70 M
|
$91.10 M
|
| Cost of Revenue |
$545.37 M |
$716.00 M |
$1.19 B |
$894.40 M |
$572.50 M |
$604.60 M |
$620.13 M |
$611.50 M |
$590.20 M |
$236.90 M |
| Gross Profit |
$318.13 M |
$288.20 M |
$581.50 M |
$541.00 M |
$329.40 M |
$385.70 M |
$345.88 M |
$610.20 M |
-$98.50 M |
-$145.80 M |
| Gross Profit Ratio |
0.37 |
0.29 |
0.33 |
0.38 |
0.37 |
0.39 |
0.36 |
0.5 |
-0.2 |
-1.6 |
| Research and Development
Expenses |
$89.59 M
|
$73.90 M
|
$76.80 M
|
$75.30 M
|
$117.90 M
|
$125.60 M
|
$126.44 M
|
$111.20 M
|
$99.49 M
|
$83.57 M
|
| General & Administrative
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Selling, General &
Administrative Expenses |
$300.56 M
|
$372.70 M
|
$468.90 M
|
$355.60 M
|
$343.30 M
|
$358.40 M
|
$414.63 M
|
$490.90 M
|
$196.58 M
|
$57.94 M
|
| Other Expenses |
$85.00 M |
$87.80 M |
$50.30 M |
$56.40 M |
$64.80 M |
-$6.00 M |
$10.46 M |
-$200,000.00 |
-$39.50 M |
-$25.20 M |
| Operating Expenses |
$475.15 M |
$534.40 M |
$596.00 M |
$487.30 M |
$526.00 M |
$551.90 M |
$625.74 M |
$666.50 M |
$349.93 M |
$152.43 M |
| Cost And Expenses |
$1.02 B |
$1.25 B |
$1.79 B |
$1.38 B |
$1.10 B |
$1.16 B |
$1.25 B |
$1.28 B |
$590.20 M |
$236.90 M |
| Interest Income |
$3.98 M |
$1.98 M |
$28,000.00 |
$152,000.00 |
$1.71 M |
$1.24 M |
$610,000.00 |
$478,000.00 |
$255,000.00 |
$771,000.00 |
| Interest Expense |
$13.51 M |
$12.06 M |
$18.88 M |
$21.93 M |
$21.52 M |
$11.89 M |
$6.60 M |
$7.43 M |
$8.42 M |
$12.26 M |
| Depreciation &
Amortization |
$105.30 M
|
$108.66 M
|
$78.72 M
|
$85.36 M
|
$93.81 M
|
$97.34 M
|
$102.09 M
|
$96.58 M
|
$42.25 M
|
$14.93 M
|
| EBITDA |
-$65.52 M
|
-$270.81 M
|
$83.57 M
|
$139.09 M
|
-$189.64 M
|
-$68.04 M
|
-$163.23 M
|
$30.46 M
|
-$87.33 M
|
-$143.84 M
|
| EBITDA Ratio |
-0.08 |
-0.18 |
0 |
0.07 |
-0.06 |
-0.09 |
-0.17 |
0.02 |
-0.2 |
-1.6 |
| Operating Income Ratio
|
-0.18
|
-0.25
|
-0.03
|
0.04
|
-0.22
|
-0.17
|
-0.29
|
-0.06
|
-0.2
|
-1.6
|
| Total Other
Income/Expenses Net |
-$27.30 M
|
-$165.27 M
|
-$33.40 M
|
-$9.03 M
|
-$30.91 M
|
-$6.07 M
|
$4.52 M
|
-$23.55 M
|
-$39.52 M
|
-$25.21 M
|
| Income Before Tax |
-$184.32 M |
-$391.50 M |
-$14.00 M |
$48.70 M |
-$304.90 M |
-$177.20 M |
-$271.92 M |
-$73.50 M |
-$138.00 M |
-$171.00 M |
| Income Before Tax Ratio
|
-0.21
|
-0.39
|
-0.01
|
0.03
|
-0.34
|
-0.18
|
-0.28
|
-0.06
|
-0.28
|
-1.88
|
| Income Tax Expense |
$4.44 M |
-$63.50 M |
$15.50 M |
$17.60 M |
$7.10 M |
-$38.70 M |
$18.86 M |
-$56.10 M |
-$113.70 M |
$24,000.00 |
| Net Income |
-$188.86 M |
-$328.00 M |
-$29.50 M |
$30.59 M |
-$312.00 M |
-$153.00 M |
-$305.25 M |
-$25.10 M |
-$30.00 M |
-$171.70 M |
| Net Income Ratio |
-0.22 |
-0.33 |
-0.02 |
0.02 |
-0.35 |
-0.15 |
-0.32 |
-0.02 |
-0.06 |
-1.88 |
| EPS |
-0.25 |
-0.46 |
-0.0455 |
0.0477 |
-0.52 |
-0.27 |
-0.55 |
-0.05 |
-0.0615 |
-0.41 |
| EPS Diluted |
-0.25 |
-0.46 |
-0.0455 |
0.0477 |
-0.52 |
-0.27 |
-0.55 |
-0.05 |
-0.06 |
-0.41 |
| Weighted Average Shares
Out |
$751.77 M
|
$719.06 M
|
$648.08 M
|
$640.66 M
|
$595.45 M
|
$563.14 M
|
$555.00 M
|
$502.00 M
|
$488.07 M
|
$418.78 M
|
| Weighted Average Shares
Out Diluted |
$751.77 M
|
$719.06 M
|
$648.08 M
|
$640.66 M
|
$595.45 M
|
$566.67 M
|
$559.16 M
|
$502.00 M
|
$500.00 M
|
$418.78 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
